Latest Industry Insights

As we discussed in our last post, the Role of Biobanking in Protecting Sample Chain of Custody, biobanks serve as biospecimen libraries as well as sample data, validation, and reference sources for both research and clinical labs.

This blog series will examine current and foreseen challenges for biobanks, as well as the systems and practices that mitigate these challenges.

Dr. Eric Kelsic, CEO and co-founder of Dyno Therapeutics, explains how AI could reduce the cost of gene therapy delivery to $0.

The Discovery Spark program aims to help upcoming biotechnology and healthcare companies grow. In this article, we take a closer look at some of the innovative technologies of this year's Discovery Spark cohort.

In this interview, Simon Wieninger discusses the critical role digital tools play in improving bioprocessing efficiency, how cloud technologies and data harmonization can overcome key challenges and the importance of maintaining robust data security.

In an interview with Technology Networks, Dr. Frederic Cedrone, vice president of corporate innovation at Catalent, discussed the challenges faced and solutions found by companies developing iPSC-derived cell therapies.

In this interview, Technology Networks spoke with Dr. Jingwen Ding, senior applications scientist at SCIEX, to understand how charge variant analysis and advanced technologies can enhance biopharmaceutical workflows.

We reached out to start-ups at ELRIG Drug Discovery 2024 to see how AI and bioengineering can be applied in biotech and drug discovery.

Technology Networks spoke to Dr. Dan Strange, CTO at Cellular Origins, to discuss how integrating proven tools and technologies, such as automation, helps cell therapy companies scale up production.

In this interview, Dr. Graeme Daniels, Sphere Fluidics, shares how advanced microfluidics are set to revolutionize biotherapeutic workflows and discusses the technology's future potential in broader applications, including cell and gene therapy.